US equities |
SPCX $167.42 ▲+5.32% NVDA $236.08 ▲+0.91% MU $1,065.49 ▼-0.87% TSLA $378.19 ▲+2.05% MSFT $526.10 ▲+1.65% SNDK $1,710.03 ▼-0.58% INTC $117.30 ▼-1.70% META $744.61 ▲+2.27%
FinancialContent

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.995 -0.005 (-0.25%)
Delayed Quote Updated: 12:40 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Price 1.995
Open 2.000
Prev. Close 2.000
Change
-0.00
% Change
-0.25%
Bid (Size) 1.990 (1,700)
Ask (Size) 2.000 (1,300)
High 2.005
Low 1.955
52 Week High 2.610
52 Week Low 1.330
EPS 0.4800
Price / Earnings 4.156
Dividend Yield N/A
Shares Outstanding 31,056,238
Volume 135,934
Average Volume (3 Mo) 677K

Chart

Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Price Performance

YTD
+0.05 (2.31%)
1 Month
-0.50 (-20.20%)
3 Month
+0.02 (0.76%)
6 Month
+0.21 (11.45%)
1 Year
+0.38 (23.15%)